A Phase Ib Study of Varlitinib in Japanese Subjects With Advanced or Metastatic Solid Tumours
Phase of Trial: Phase I
Latest Information Update: 06 Jul 2018
At a glance
- Drugs Capecitabine (Primary) ; Varlitinib (Primary)
- Indications Biliary cancer; Solid tumours
- Focus Adverse reactions
- Sponsors ASLAN Pharmaceuticals
- 27 Jun 2018 Status changed from active, no longer recruiting to completed.
- 08 Jan 2018 Status changed from recruiting to active, no longer recruiting.
- 08 Mar 2017 New trial record